Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADH1A |
| Upstream (Parents) |
|---|
| (<<) F9 → ADH1A |
| Downstream (Children) |
|---|
| ADH1A → GYS2 (>>) |
| ADH1A → GLYAT (>>) |
| ADH1A → CFHR2 (>>) |
| ADH1A → DIO1 (>>) |
| ADH1A → AOX1 (>>) |
| ADH1A → DPYS (>>) |
| ADH1A → SLC10A1 (>>) |
| ADH1A → FMO3 (>>) |
| ADH1A → GATM (>>) |
| ADH1A → C2///CFB (>>) |
